Pfizer Inc (PFE)
Operating profit margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Operating income | US$ in thousands | 14,938,000 | 3,359,000 | 40,030,000 | 24,833,000 | 10,630,000 |
| Revenue | US$ in thousands | 63,627,000 | 58,496,000 | 100,330,000 | 81,288,000 | 41,908,000 |
| Operating profit margin | 23.48% | 5.74% | 39.90% | 30.55% | 25.37% |
December 31, 2024 calculation
Operating profit margin = Operating income ÷ Revenue
= $14,938,000K ÷ $63,627,000K
= 23.48%
Based on the provided data, Pfizer Inc's operating profit margin has experienced fluctuations over the past five years. In December 31, 2020, the operating profit margin was 25.37%, showing a positive performance. This margin increased to 30.55% by December 31, 2021, indicating an improvement in profitability.
By December 31, 2022, Pfizer's operating profit margin significantly rose to 39.90%, demonstrating strong profitability during that period. However, there was a notable decline in the operating profit margin to 5.74% by December 31, 2023, suggesting potential challenges or issues impacting profitability.
In December 31, 2024, the operating profit margin increased again to 23.48%, showing signs of recovery from the previous year's decline. Overall, the company has shown varying levels of operating profitability over the years, with notable fluctuations that may require further analysis to understand the underlying factors driving these changes.
Peer comparison
Dec 31, 2024